Page 4 - Medicines

India sends relief material including medicines to cholera-affected Zambia

India has sent relief material, including medicines, to Zambia to help it deal with an outbreak of cholera, External Affairs Minister S Jaishankar said on Saturday. He said India stands with Zambia in this "trying time". "India sends Humanitarian Assistance to Zambia in wake of the cholera outbreak," Jaishankar posted on X along with a photograph of relief material consignments. "The aid weighing approx 3.5 tons comprises water purification supplies, chlorine tablets and ORS sachets. Was handed over today by our High Commissioner to the Government of Zambia," he said.

TechEagle partners with 10 Aiims for fast medicine delivery via drones

Drone logistics company TechEagle on Monday said it has entered into collaborations with 10 AIIMS for the fast delivery of medicines. "TechEagle's nationwide impact is underscored by...collaborations with 10 AIIMS & INI's hospitals, swiftly implementing drone services and setting new range and speed records," the company said in a statement. In a significant trial, TechEagle transported a medical payload of up to five kilogram to rural primary health centres at AIIMS Rajkot and AIIMS Mangalagiri. "At TechEagle, we see a future where drones play a key role in solving India's healthcare challenges. The quick implementation of BVLOS (Beyond Visual Line of Sight) drone delivery services in 10 AIIMS & INI's hospitals underlines our commitment to improving healthcare logistics for our country with safety and reliability," TechEagle founder and CEO Vikram Singh Meena said. TechEagle had earlier said its drone transported essential tuberculosis medicine in just 34 minutes. During its .

Amended biological diversity law raises fear of loss for tribals

The mandated percentage of earnings that goes as ABS ranges from 0.1 to 0.5 per cent of sales, depending on the company's revenue, according to AYUSH industry estimates

DGHS asks pharmacists to dispense antibiotics only on doctor's prescription

DGHS Atul Goel appealed to all pharmacists to strictly implement Schedules H and H1 of the Drugs and Cosmetics Rules, 1945, with regards to selling antibiotics

Implementing revised Schedule M rules uphill task for small pharma

Analysts also feel this move will help improve quality of Indian drugs

ICRA predicts 9-11% growth in FY24 fuelled by new launches, US rebound

ICRA anticipates expansion in revenues for its sample set of 25 companies, which represent approximately 60 per cent of the overall revenues of the Indian pharmaceutical industry

Lupin expands global portfolio with acquisition of assets from Sanofi

The deal involves the acquisition of a portfolio of accretive established products in Europe and Canada

Zydus Lifesciences gets final FDA nod for Darunavir for HIV-1 treatment

According to market research firm IQVIA, Darunavir Tablets, 75 mg, 150 mg, 600 mg, and 800 mg had annual sales of $275 million in the US

Loss of patents: Indian pharma companies gain, shows PharmaTrac data

While MNCs posted a 5 per cent five-year compound annual growth rate (CAGR) in the chronic segment, Indian pharma companies have recorded a 9 per cent 5-year CAGR

Mefenamic acid can have adverse reactions; govt issues drug safety alert

The Indian Pharmacopoeia Commission (IPC) states that painkiller Meftal can cause adverse reactions, including drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome

Painkiller Meftal can trigger adverse reactions!

Alert! Painkiller Meftal could cause DRESS syndrome. Watch the video to know how this drug can be effective but risky. >

Maldives reports contamination in Pakistani syrups, suspension medicines

The report prompted the World Health Organisation to issue an alert urging countries to step up vigilance and test products manufactured by a Lahore-based pharmaceutical company, according to Dawn

Indian pharma industry can grow to $450 bn by 2047: EY-OPPI report

The report underlines the need for collaboration and alignment between the industry, academia and government to advance research and innovation capabilities

Medicines for four rare diseases become cheaper due to domestic production

Medicines for four rare diseases have become available at drastically cheaper rates as Indian pharma companies are now producing them reducing the reliance on expensive imported formulations, Union Health Ministry officials said on Friday. The slashing of prices comes as the ministry has prioritised action related to 13 rare diseases along with sickle cell anaemia. Drugs for four of these diseases -Tyrosinemia Type 1, Gaucher's Disease, Wilson's Disease and Dravet-Lennox Gastaut Syndrome - along with sickle cell Anemia have been approved and are being manufactured indigenously. Four more drugs for three diseases - Tablet Sapropterin for Phenylketonuria, tab Sodium Phenyl Butyrate and tablet Carglumic Acid for Hyperammonemia and Capsule Miglustat for Gaucher's disease - are under process for approval and are likely to be available by April 2024, official sources said. With these drugs being manufactured indigenously, the annual cost of Nitisinone capsules, used in the treatment of .

SC cautions Patanjali over making 'false' claims about its medicines in ads

The Supreme Court Tuesday cautioned Patanjali Ayurved, a company co-founded by yoga guru Ramdev and dealing in herbal products, against making "false" and "misleading" claims in advertisements about its medicines as cure of several diseases. "All such false and misleading advertisements of Patanjali Ayurved have to stop immediately. The court will take any such infraction very seriously...," a bench comprising justices Ahsanuddin Amanullah and Prashant Kumar Mishra orally observed while hearing a plea of the Indian Medical Association (IMA). The top court, on August 23, 2022, had issued notices to the Union health ministry and Ministry of Ayush and Patanjali Ayurved Ltd, on the plea of the IMA alleging a smear campaign by Ramdev against the vaccination drive and modern medicines. During the brief hearing, the bench asked Patanjali Ayurved not to publish misleading claims and advertisements against modern systems of medicine. It said the bench may also consider imposing a fine of Rs

Strides Pharma arm obtains USFDA nod for Levetiracetam oral solution

According to market research firm IQVIA, the Levetiracetam oral solution has a market size of $55 million

Pharma majors turn attention to OTC drugs in post-pandemic wellness shift

Building a healthy OTC brand, however, is not an easy task. OTC brands need time to grow and build a recall value once they have established some credibility

Biocon biologics receives marketing approval by MHRA for YESAFILI in UK

This approval follows the green light granted by the European Commission (EC) for marketing authorisation in the European Union (EU) back in September

India, Netherlands to cooperate on regulations for medical products

India and the Netherlands will cooperate on regulations for medical products and enhance the quality of healthcare services in both countries. At Hague, India and the Netherlands have "signed a memorandum of intent (MoI) to cooperate on medical product regulation and enhance the quality of medical products and healthcare services for both countries". The MoI was signed during a meeting of Bhagwant Khuba, Union Minister of State for Chemicals and Fertilizers with Ernst Kuipers Minister of Health, Welfare and Sports of the Kingdom of Netherlands. An Indian delegation led by Khuba is in the Netherlands to participate in the second World Local Production Forum (WLPF) meeting being held in The Hague from 6 to 8 November 2023. The World Local Production Platform is a platform created at the initiative of WHO with the aim of increasing access to medicines and other health technologies. The Minister also visited the European Medicines Agency (EMA). He met Carla van Rooijen, Director of t

IIT Guwahati discovers modified graphene oxide's potential in medicine

Researchers at the Indian Institute of Technology (IIT) Guwahati have developed cost-effective experiments for modifying graphene oxide that can be used by other academic institutions to train personnel needed for cutting-edge projects in semiconductors, nanoelectronics, healthcare and quantum technologies. A team led by Rajiv K Kar, assistant professor, at the Jyoti and Bhupat Mehta School of Health Sciences and Technology in IIT-Guwahati, have made these important discoveries regarding the use of modified graphene oxide for biomedical applications, a release said on Tuesday. Graphene is an exceptionally strong material and possesses outstanding electrical and thermal conductivity. Its oxidised form, called Graphene Oxide (GO), offers a large surface area and low cytotoxicity, making it suitable for medical applications. GO can be further engineered through defects, doping and functional modifications, which enhance its optical and electrical properties for improved biomedical ...